Fulgent Genetics Change in Accounts Payable 2015-2025 | FLGT

Fulgent Genetics change in accounts payable from 2015 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.

Fulgent Genetics Change in Accounts Payable 2015-2025 | FLGT

Fulgent Genetics change in accounts payable from 2015 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
Related Stocks
Company NameMarket
Cap
Veeva Systems (VEEV)$44B
Tempus AI (TEM)$13.2B
Doximity (DOCS)$12.7B
Hims & Hers Health (HIMS)$9.6B
IRhythm Technologies (IRTC)$5.5B
Hinge Health (HNGE)$4.4B
Privia Health (PRVA)$2.8B
Inspire Medical Systems (INSP)$2.8B
Heartflow (HTFL)$2.6B
Phreesia (PHR)$1.9B
Enovis (ENOV)$1.8B
10x Genomics (TXG)$1.7B
Omnicell (OMCL)$1.5B
Schrodinger (SDGR)$1.4B
Azenta (AZTA)$1.4B
Clover Health Investments (CLOV)$1.3B
Claritev (CTEV)$1.1B
Evolent Health (EVH)$1.1B
Zepp Health (ZEPP)$652M
Veradigm (MDRX)$531M
Standard BioTools (LAB)$481M
Talkspace (TALK)$445M
Butterfly Network (BFLY)$405M
Carlsmed (CARL)$354M
TruBridge (TBRG)$300M
Outset Medical (OM)$247M
Health Catalyst (HCAT)$239M
SOPHiA GENETICS SA (SOPH)$234M
Nyxoah SA (NYXH)$213M
KORU Medical Systems (KRMD)$195M